Clinical Trial Update: Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of methylnaltrexone in neurointensive care patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: University of Zurich | Conditions: Opioid Use, Unspecified With Other Opioid-induced Disorder | Phase 1 | Status: COMPLETED